VRK3
Serine/threonine-protein kinase VRK3
Also known as: VRK3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IV63
- Gene
- VRK3
- Ensembl
- ENSG00000105053
- Chromosome
- 19
- Canonical length
- 474 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. In both human and mouse, this gene has substitutions at several residues within the ATP binding motifs that in other kinases have been shown to be required for catalysis. In vitro assays indicate the protein lacks phosphorylation activity. The protein, however, likely retains its substrate binding capability. This gene is widely expressed in human tissues and its protein localizes to the nucleus. Alternative splicing results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
474 residues, UniProt reviewed canonical sequence.
>Q8IV63|VRK3
1 MISFCPDCGK SIQAAFKFCP YCGNSLPVEE HVGSQTFVNP HVSSFQGSKR GLNSSFETSP
61 KKVKWSSTVT SPRLSLFSDG DSSESEDTLS SSERSKGSGS RPPTPKSSPQ KTRKSPQVTR
121 GSPQKTSCSP QKTRQSPQTL KRSRVTTSLE ALPTGTVLTD KSGRQWKLKS FQTRDNQGIL
181 YEAAPTSTLT CDSGPQKQKF SLKLDAKDGR LFNEQNFFQR AAKPLQVNKW KKLYSTPLLA
241 IPTCMGFGVH QDKYRFLVLP SLGRSLQSAL DVSPKHVLSE RSVLQVACRL LDALEFLHEN
301 EYVHGNVTAE NIFVDPEDQS QVTLAGYGFA FRYCPSGKHV AYVEGSRSPH EGDLEFISMD
361 LHKGCGPSRR SDLQSLGYCM LKWLYGFLPW TNCLPNTEDI MKQKQKFVDK PGPFVGPCGH
421 WIRPSETLQK YLKVVMALTY EEKPPYAMLR NNLEALLQDL RVSPYDPIGL PMVPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VRK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 129 nTPM
Expression across tissuesHPA
Tissue
- testis: 129 nTPM
- retina: 60 nTPM
- choroid plexus: 37 nTPM
- kidney: 35 nTPM
- liver: 34 nTPM
- thymus: 33 nTPM
Single-cell type
- late spermatids: 2,917 nCPM
- early spermatids: 615 nCPM
- late primary spermatocytes: 386 nCPM
- cone photoreceptor cells: 106 nCPM
- rod photoreceptor cells: 105 nCPM
- neutrophils: 100 nCPM
Immune cell
- neutrophil: 113 nTPM
- basophil: 111 nTPM
- NK-cell: 83 nTPM
- eosinophil: 81 nTPM
- T-reg: 76 nTPM
- memory B-cell: 59 nTPM
Brain region
- midbrain: 41 nTPM
- pons: 40 nTPM
- choroid plexus: 39 nTPM
- white matter: 35 nTPM
- cerebral cortex: 34 nTPM
- thalamus: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA damage response
- negative regulation of ERK1 and ERK2 cascade
- signal transduction
- skeletal muscle tissue development
Molecular functions
- ATP binding
- cyclin-dependent protein serine/threonine kinase activity
- protein phosphatase activator activity
- protein phosphatase binding
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Protein kinase-like domain superfamily
- Casein kinase 1/Serine/threonine-protein kinase-like
- Protein kinase domain
- Zinc-ribbon domain
- zinc-ribbon domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VRK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VRK3 as an antibody target. Whether an autoantibody or antibody against VRK3 could matter depends on whether native VRK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VRK3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label VRK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...